EMILY WELTY: Open Payments
NPI 1780155911 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$804 in 20 payments from 10 companies in 2025. Trend: 2023 $324 · 2024 $671 · 2025 $804
Food & beverage: $804
| Company | Payments | Amount |
|---|---|---|
| Ethicon US, LLC | 2 | $213 |
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Ardelyx, Inc. | 1 | $114 |
| Gilead Sciences, Inc. | 5 | $97 |
| GENZYME CORPORATION | 3 | $73 |
| ABBVIE INC. | 3 | $64 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| PFIZER INC. | 1 | $30 |
| Novo Nordisk Inc | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
Products named: LINX REFLUX MANAGEMENT SYSTEM, IBSRELA, DUPIXENT, LINZESS, ZENPEP, VELSIPITY, Wegovy, VIBERZI.
Industry payments across VA — which companies pay providers there.
